2018 annual financial data
Biodexa Pharmaceuticals 2018 Operating margin
Direct answer
Operating margin was -609.65%.
Operating income was -11,815,000 USD and net income was -10,368,000 USD.
Operating cash flow was -13,450,000 USD.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,938,000 USD
- Operating income
- -11,815,000 USD
- Net income
- -10,368,000 USD
- Operating cash flow
- -13,450,000 USD